Estimated number of new cancer cases for 2021, excluding basal cell and squamous cell skin cancers and in situ carcinomas except urinary bladder.
Protein disulphide isomerase inhibition as a potential cancer therapeutic strategy.
Inhibitors of the protein disulfide isomerase family for the treatment of multiple myeloma.
Downregulation of PDia3 inhibits proliferation and invasion of human acute myeloid leukemia…
The protein disulfide isomerases PDIA4 and PDIA6 mediate resistance to cisplatin-induced cell death in lung adenocarcinoma
Protein disulfide isomerase: a promising target for cancer therapy
Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment